53BP1 sensitizes breast cancer cells to 5-fluorouracil.

Title53BP1 sensitizes breast cancer cells to 5-fluorouracil.
Publication TypeJournal Article
Year of Publication2013
AuthorsLi X, Kong X, Kong X, Wang Y, Yan S, Yang Q
JournalPloS one
Volume8
Issue9
Paginatione74928
Date Published2013
Abstract

Chemoresistance of breast cancer is a worldwide problem for breast cancer and the resistance to chemotherapeutic agents frequently led to the subsequent recurrence and metastasis. In our previous study, we have found that 53BP1 showed a gradual decrease during the progression of breast cancer and loss of 53BP1 was associated with metastasis and poor prognosis in breast cancer. Here we aimed to reveal whether 53BP1 could sensitize breast cancer to 5-Fu. We found that ectopic expression of 53BP1 can significantly sensitize breast cancer cells to 5-Fu while knockdown of 53BP1 conferred the resistance. The in vivo experiments confirmed that overexpression of 53BP1 in combination with 5-Fu markedly inhibited growth of xenotransplanted tumors in nude mice when compared to either agent alone. Furthermore, we demonstrated that 53BP1 regulated the sensitivity to 5-Fu through thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPYD). The present studies provide a new clue that combination of 5-Fu and 53BP1 could be a potential novel targeted strategy for overcoming breast cancer chemoresistance.

DOI10.1371/journal.pone.0075479
Alternate JournalPLoS ONE